Hsiung Feng 4
4 · Senti Biosciences, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Hsiung Feng
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-07+43,900→ 43,900 totalExercise: $3.52Exp: 2035-03-06→ Common Stock (43,900 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in 36 substantially equal monthly installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date.